Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
July 28, 2021
Share
Laboratorio Reig Jofre, S.A. Announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was EUR 116.115 million compared to EUR 115.826 million a year ago. Operating income was EUR 4.668 million compared to EUR 4.849 million a year ago. Net income was EUR 3.563 million compared to EUR 3.861 million a year ago.
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Companyâs activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
LABORATORIO REIG JOFRE, S.A. 
